|
ALX-201-336 |
Nampt/Visfatin (human) (recombinant) |
|
|
|
ALX-201-364 |
Nampt/Visfatin (mouse) (recombinant) |
|
|
|
ALX-201-318 |
Nampt/Visfatin (mouse) (recombinant) (His) |
|
|
|
ALX-201-366 |
Nampt/Visfatin (rat) (recombinant) |
|
|
|
ALX-201-332 |
Nampt/Visfatin (rat) (recombinant) (His) |
|
|
|
AG-V0523 |
Nampt/Visfatin (human) ELISA Kit |
|
|
|
AG-N0823 |
Nampt/Visfatin (human) (IntraCellular) ELISA Kit |
|
|
|
AG-VN0812 |
Nampt/Visfatin (mouse) ELISA Kit |
|
|
|
AG-N0812 |
Nampt/Visfatin (mouse) (IntraCellular) ELISA Kit |
|
|
|
ALX-270-102 |
Naproxen |
|
|
|
ALX-163-011 |
NBD Peptide / NF-κB Blocker (cell permeable) |
|
|
|
ALX-350-146 |
Neobavaisoflavone |
|
|
|
ALX-380-088 |
Netropsin . dihydrochloride |
|
|
|
ALX-201-285 |
NF-κB (p50) (human) (recombinant) (His) |
|
|
|
ALX-201-284 |
NF-κB (p65) (human) (recombinant) (His) |
|
|
|
ALX-460-008 |
Nicotinamide |
|
|
|
ALX-460-009 |
Nicotinic acid |
|
|
|
ALX-380-050 |
Nigericin . sodium salt |
|
|
|
ALX-480-058 |
8-Nitroguanine |
|
|
|
ALX-201-237 |
NMNAT1 (human) (recombinant) (His) |
|
|
|
ALX-201-429 |
NMNAT1 (human) (recombinant) (His) |
|
|
|
ALX-201-238 |
NMNAT3 (human) (recombinant) |
|
|
|
ALX-380-295 |
Norfloxacin |
|
|
|
ALX-380-296 |
Norfloxacin nicotinate |
|
|
|
ALX-380-093 |
Novobiocin . sodium salt |
|
|
|
ALX-270-370 |
NU1025 |
|
|
|
ALX-270-302 |
Nullscript |
|
|
|
ALX-350-308 |
3-O-Acetyl-β-boswellic acid |
|
|
|
ALX-380-297 |
Ofloxacin |
|
|
|
ALX-550-398 |
N-Oleoyldopamine |
|
|
|
ALX-300-150 |
Oleoylethanolamide |
|
|
|
ALX-270-379 |
Oxamflatin |
|
|
|
ALX-350-301 |
Oxaspirodion |
|
|
|
ALX-350-109 |
Panepoxydone |
|
|
|
ALX-202-045 |
PARG (bovine) |
|
|
|
ALX-202-042 |
PARP-1 (bovine) (~90%) |
|
|
|
ALX-202-046 |
PARP-1 (bovine) (~98%) |
|
|
|
ALX-202-044 |
PARP-1 (bovine) (automodified) Standard |
|
|
|
ALX-201-063 |
PARP-1 (human) (recombinant) (high purity) |
|
|
|
ALX-201-254 |
PARP-1 (E988K mutant) (human) (recombinant) (Control) |
|
|
|
ALX-201-250 |
PARP-1 (human) (recombinant) (high purity) (His) |
|
|
|
ALX-201-255 |
PARP-1 (BRCT Domain) (human) (recombinant) (His) |
|
|
|
ALX-201-232 |
PARP-1 (Catalytic Domain) (human) (recombinant) (His) |
|
|
|
ALX-201-253 |
PARP-1b (human) (recombinant) (active) (His) |
|
|
|
ALX-201-064 |
PARP-2 (mouse) (recombinant) (high purity) |
|
|
|
ALX-201-251 |
PARP-2 (mouse) (recombinant) (high purity) (His) |
|
|
|
ALX-201-170 |
PARP-3 (human) (recombinant) (high purity) |
|
|
|
ALX-201-252 |
PARP-3 (human) (recombinant) (high purity) (His) |
|
|
|
ALX-350-258 |
Parthenolide |
|
|
|
ALX-300-301 |
PAz-PC |
|
|
|
ALX-201-281 |
PCAF (mouse) (recombinant) (His) |
|
|
|
ALX-380-298 |
Pefloxacin . mesylate . dihydrate |
|
|
|
ALX-400-036 |
Peroxynitrite . tetramethylammonium |
|
|
|
ALX-270-251 |
6(5H)-Phenanthridinone |
|
|
|
ALX-850-286 |
Phospho-IκBα ActivELISA™ Assay Kit |
|
|
|
ALX-270-367 |
Pioglitazone |
|
|
|
ALX-270-289 |
PJ-34 |
|
|
|
ALX-630-086 |
Podophyllotoxin |
|
|
|
ALX-202-043 |
Poly(ADP-ribose) Standard |
|
|
|
ALX-215-025 |
PAb to 14-3-3ε (NT) |
|
|
|
ALX-210-708 |
PAb to 14-3-3 (human) |
|
|
|
ALX-215-028 |
PAb to 14-3-3τ |
|
|
|
ALX-215-029 |
PAb to 14-3-3ζ |
|
|
|
ALX-215-030 |
PAb to 14-3-3 |
|
|
|
ALX-215-021 |
PAb to 14-3-3β |
|
|
|
ALX-215-026 |
PAb to 14-3-3β/ζ (phosphorylated) (pSer185) |
|
|
|
ALX-215-022 |
PAb to 14-3-3ε (CT) |
|
|
|
ALX-215-023 |
PAb to 14-3-3η |
|
|
|
ALX-215-024 |
PAb to 14-3-3γ |
|
|
|
ALX-215-027 |
PAb to 14-3-3σ |
|
|
|
ALX-210-370 |
PAb to ABIN-2 |
|
|
|
ALX-210-245 |
PAb to Ah Receptor Nuclear Translocator 3 |
|
|
|
ALX-210-150 |
PAb to Ah Receptor Nuclear Translocator (mouse) |
|
|
|
ALX-210-255 |
PAb to AIB1 (human) |
|
|
|
ALX-210-151 |
PAb to Androgen Receptor |
|
|
|
ALX-210-152/1 |
PAb to Androgen Receptor |
|
|
|
ALX-210-552 |
PAb to Apurinic/Apyrimidinic Endonuclease |
|
|
|
ALX-210-723 |
PAb to Apurinic/Apyrimidinic Endonuclease |
|
|
|
ALX-215-038 |
PAb to ART1 (mouse) |
|
|
|
ALX-215-037 |
PAb to ART1 (human) |
|
|
|
ALX-215-039 |
PAb to ART2.2 (mouse) |
|
|
|
ALX-215-042 |
PAb to ART4 (human) |
|
|
|
ALX-210-905 |
PAb to Asc (AL177) |
|
|
|
ALX-210-803 |
PAb to Ataxia telangiectasia Mutated (human) |
|
|
|
ALX-210-798 |
PAb to ATR (human) |
|
|
|
ALX-210-066 |
PAb to ATRIP (human) |
|
|
|
ALX-210-929 |
PAb to Cardif (human) (AT107) |
|
|
|
ALX-210-903 |
PAb to CARMA1 (AL220) |
|
|
|
ALX-210-804 |
PAb to Caspase-1 |
|
|
|
ALX-210-809 |
PAb to Caspase-5 |
|
|
|
ALX-210-243 |
PAb to CLOCK (NT) |
|
|
|
ALX-210-244 |
PAb to CLOCK (mouse) (CT) |
|
|
|
ALX-210-229 |
PAb to CREB Binding Protein |
|
|
|
ALX-210-910 |
PAb to CYLD (human) (AF888) |
|
|
|
ALX-210-416 |
PAb to Deoxyribonuclease I |
|
|
|
ALX-210-530 |
PAb to DMPO |
|
|
|
ALX-210-553 |
PAb to DNA Polymerase β |
|
|
|
ALX-210-330 |
PAb to Dnmt 2 |
|
|
|
ALX-210-893 |
PAb to EGR-4 Protein |
|
|
|
ALX-210-201 |
PAb to Estrogen Receptor α |
|
|
